Paolo Golfetto, Ompi discusses changing pharmaceutical operations for parenterals through a new flexible concept.
Today pharmaceutical companies face a high amount of costs for developing new parenteral drugs and there are many cases of patent losses. There is the need to offer them new manufacturing solutions as their target in this scenario is to lower cost pressure, increase flexibility and quality, reduce time to market and outsource non core activities.
Ompi aims to ease these problems providing a new filling platform based on a new flexible concept.